|
Volumn 64, Issue 2, 2011, Pages 144-147
|
18FDG PET/CT is a powerful tool for detecting subclinical arthritis in patients with psoriatic arthritis and/or psoriasis vulgaris
|
Author keywords
Enthesitis; PET CT; Subclinical PsA; TNF inhibitors
|
Indexed keywords
ADALIMUMAB;
FLUORODEOXYGLUCOSE;
INFLIXIMAB;
TUMOR NECROSIS FACTOR INHIBITOR;
ADULT;
ARTHRITIS;
BONE SCINTISCANNING;
CLINICAL ARTICLE;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DISEASE ACTIVITY;
DISEASE ACTIVITY SCORE;
DRUG EFFICACY;
EARLY DIAGNOSIS;
ENTHESITIS;
FEMALE;
HUMAN;
INTERMETHOD COMPARISON;
LETTER;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
PSORIASIS AREA AND SEVERITY INDEX;
PSORIASIS VULGARIS;
PSORIATIC ARTHRITIS;
SCORING SYSTEM;
SENSITIVITY AND SPECIFICITY;
SKIN DEFECT;
ADULT;
AGED;
ARTHRITIS, PSORIATIC;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
MALE;
MIDDLE AGED;
POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;
RADIOPHARMACEUTICALS;
|
EID: 80053384121
PISSN: 09231811
EISSN: 1873569X
Source Type: Journal
DOI: 10.1016/j.jdermsci.2011.08.002 Document Type: Letter |
Times cited : (26)
|
References (9)
|